The Use of Serum Trypsin-like Immunoreactivity for the Diagnosis of Canine Exocrine Pancreatic Insufficiency by Hall, D. J. & Hagemoser, W. A.
Volume 52 | Issue 1 Article 3
1990
The Use of Serum Trypsin-like Immunoreactivity






Follow this and additional works at: https://lib.dr.iastate.edu/iowastate_veterinarian
Part of the Diagnosis Commons, Digestive System Diseases Commons, and the Small or
Companion Animal Medicine Commons
This Article is brought to you for free and open access by the Journals at Iowa State University Digital Repository. It has been accepted for inclusion in
Iowa State University Veterinarian by an authorized editor of Iowa State University Digital Repository. For more information, please contact
digirep@iastate.edu.
Recommended Citation
Hall, D. J. and Hagemoser, W. A. (1990) "The Use of Serum Trypsin-like Immunoreactivity for the Diagnosis of Canine Exocrine
Pancreatic Insufficiency," Iowa State University Veterinarian: Vol. 52 : Iss. 1 , Article 3.
Available at: https://lib.dr.iastate.edu/iowastate_veterinarian/vol52/iss1/3
The Use of Serum Trypsin-like Immunoreactivity for the Diagnosis
of Canine Exocrine Pancreatic Insufficiency
D J Hall, DVM*
W A Hagemoser, DVM, PhD**
Introduction
Exocrine pancreatic insufficiency (EPI) is an
important cause of malassimilation in the dog.
Due to the unreliability of available diagnostic
procedures in the past the prevalence of EPI
has probably been exaggerated.1 A new proce-
dure has recently been developed and is proving
to be highly sensitive and highly specific for the
measurement of exocrine pancreatic function.
This test, a radioimmunoassay of serum tryp-
sin-like immunoreactivity, shows pronlise for
more accurately distinguishing between EPI
and small intestinal disease as the cause of
malassimilation.
Exocrine Pancreatic Insufficiency
A failure of the pancreas to produce and se-
crete adequate digestive enzymes results in
nutrient maldigestion and subsequent malnu-
trition. This syndrome is known as exocrine
pancreatic insufficiency. Juvenile pancreatic
acinar atrophy, chronic relapsing pancreatitis,
and, rarely, severe acute pancreatitis and neo-
plasia can lead to this condition.1,2,3,4 The pan-
creas has considerable functional reserve but
when greater than 90% of the acinar mass is
destroyed or nonfunctional the concentrations
of alpha-amylase, pancreatic proteases, and
lipase secreted into the small intestine fall
below critical levels.1,2,4 Maldigestion ofstarches,
proteins and triglycerides ensues and clinical
signs of malassimilation and malnutrition
appear. Clinical signs ofEPI include diarrhea,
steatorrhea, weight loss, ravenous appetite,
voluminous and malodorous fecal mass
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often containing undigested food elements,
excessive borborygmus, coprophagia, abdomi-
nal distension and general signs ofnlalnutrition.
2,3,4,5 Affected dogs usually remain active and
alert. It is difficult to distinguish on the basis of
these clinical signs whether the malassimila-
tion is of pancreatic or small intestinal origin.
Since treatment for exocrine pancreatic insuffi-
ciency consists of expensive oral pancreatic
enzyme supplementation, it is important to
distinguish those dogs that will benefit from
this therapy from those which will not. 2,6,7
Previously Available Diagnostic Tests
A variety of tests have been utilized to aid in
the diagnosis of EPI which include the micro-
scopic examination of feces, measurenlent of
fecal proteolytic activity and oral fat absorption
tests with and without added digestive en-
zymes. More recently a synthetic peptide (BT-
PABA) has been utilized to evaluate pancreatic
output of chymotrypsin. 2 The sensitivity and
specificity of each of these methods as well as
their practicality have been questioned and a
search for a more satisfactory test continues.
4,5.6
Radioimmunoassay of Trypsin-like Im-
munoreactivity
Recent studies and case reports of a radi-
oimmunoassay oftrypsin-like immunoreactiv-
ity (TLI) in canine serum suggest that it is a
more sensitive and specific indicator ofexocrine
pancreatic insufficiency.6,7,8,9,10
The classical radioimmunoassay techniques
employed make use of antibodies raised in
rabbits against canine cationic trypsin.6,7 The
imnlunoreactivity of the canine patient serum
refers to the concentration of proteins recog-
nized by these antibodies. Trypsinogen, free
trypsin, and trypsin complexed with inhibitor
molecules bind these antibodies equally well,
hence the term "trypsin-like immunoreactiv-
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ity".7 In the absence of pancreatitis, however,
only trypsinogen is present in serum.8 There is
no significant cross-reactivity with anionic
trypsinogen and trypsin, nor-chymotrypsin. 10
As trypsinogen is produced and secreted only by
pancreatic acinar cells this assay is pancreas
specific. 6,10
Trypsinogen, the inactive zymogen of tryp-
sin, is produced by pancreatic acinar cells and
secreted into the small intestine. Enterokinase
in the small intestine cleaves the trypsinogen
into the active enzyme. No detectable levels of
trypsinogen nor trypsin are absorbed from the
intestinal lumen. Rather, 0.1% to 0.01% of the
trypsinogen synthesized daily leaks from the
pancreas directly into the blood stream. 6,7
Present as cationic and anionic isoenzymes, the
trypsinogen has a very short half-life. It is
rapidly filtered at the glomerulus, especially
the cationic form, and is metabolized by renal
tubular cells. This leakage from the pancreas
results in a consistent low level of trypsinogen
being present in the serum of normal dogs.
A single serum sample is all that is needed
from the patient.7,8 This sample should be
drawn after a fast ofat least twelve hours. TLI
is stable in serum for several days at room
temperature so it can be shipped to a laboratory
with no special packing considerations. 6,7
Prolonged exposure to heat during shipping
has been blamed for sonle equivocal results
seen in one laboratory.6 Dogs already on pan-
creatic enzyme supplementation do not need to
undergo a withdrawal period as this therapy
has no effect on the assay. 6,9
All of the studies ofTLI have revealed it to
be highly sensitive and highly specific for exo-
crine pancreatic insufficiency. Compared to
normal dogs and dogs exhibiting steatorrhea
secondary to small intestinal disease, the TLI
levels in dogs with EPI are consistently and
significantly subnormal.8 Dogs with clinical
EPI have had TLI concentrations <2.5 ug/L.
Values in normal dogs and those with small
intestinal disease are not significantly differ-
ent and have been in the range of 5.0 ug/L to
35.0 uglL. 6,9
Occasionally, results fall into a "gray zone"
between 2.5 uglL and 5.0uglL. The situations in
which this may occur have been reasonably
explained. In some dogs with EPI a transient
increase in serum TLI is seen after feeding.6
These values usually return to <2.5ug/L within
three hours. This phenomenon stresses the
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importance of sampling only after fasting the
animal. Dogs which have experienced chronic
relapsing pancreatitis may have values in the
2.5 to 3.0 uglL range with some showing clinical
signs ofEPI and others not, depending on extra-
pancreatic digestive capabilities. Higher levels
seen with chronic relapsing pancreatitis may
be attributable to inflammation of residual
pancreatic tissue.6 Some dogs with subclinical
EPI have measured TLI >3.0 ug/L. Dogs tested
earlier in the course of the disease than those
used in the reported studies may show higher
concentrations even when the EPI is clinical. It
is also possible for a normal dog to have low TLI
if it has been on a prolonged low protein diet.
The values in these dogs probably will not fall
below 4.0 ug/L.
The assay of serum TLI does have it's limita-
tions in certain situations. A case ofEPI secon-
dary to pancreatic duct obstruction can still
have normal serum TLI as synthesis of tryp-
sinogen is not the underlying problem.6 The
same is true in animals with a congenital defi-
ciency ofother pancreatic enzymes or intestinal
enterokinases, although these conditions have
not yet been reported in dogs.6
Increased serum trypsin-like immunoreac-
tivity can be seen in early stages of acute pan-
creatitis, with severe renal dysfunction, and
possibly in cases ofextreme malnutrition.6 The
use of this parameter to diagnose pancreatitis
has been considered but has disadvantages for
use in azotemic patients just as amylase and
lipase determinations do.
Conclusions
There is an increasing number of reports
supporting the usefulness of trypsin-like im-
munoreactivity in diagnosing exocrine pancre-
atic insufficiency in the canine patient. In any
case of steatorrhea it can be used to determine
ifsmall intestinal disease or pancreatic insuffi-
ciency is the underlying cause ofthe malassimi-
lation. Currently available in only a small
number of laboratories in the United States, it
has not gained widespread recognition and
acceptance. The assay's high specificity, sensi-
tivity, and ease should soon make it highly
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